582 reports of this reaction
1.9% of all MUPIROCIN CALCIUM reports
#10 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #10 most commonly reported adverse reaction for MUPIROCIN CALCIUM, manufactured by NORTHSTAR RX LLC. There are 582 FDA adverse event reports linking MUPIROCIN CALCIUM to CHRONIC KIDNEY DISEASE. This represents approximately 1.9% of all 31,213 adverse event reports for this drug.
Patients taking MUPIROCIN CALCIUM who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a less commonly reported adverse event for MUPIROCIN CALCIUM, but still significant enough to appear in the safety profile.
In addition to chronic kidney disease, the following adverse reactions have been reported for MUPIROCIN CALCIUM:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 582 FDA reports for MUPIROCIN CALCIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 1.9% of all adverse event reports for MUPIROCIN CALCIUM, making it a notable side effect.
If you experience chronic kidney disease while taking MUPIROCIN CALCIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.